Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet's disease.,European Journal of Gastroenterology & Hepatology

当前位置： X-MOL 学术 › Eur. Gastroenterol. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet's disease.
European Journal of Gastroenterology & Hepatology ( IF 2.1 ) Pub Date : 2024-02-23 , DOI: 10.1097/meg.0000000000002711
Hye Kyung Hyun ₁ , Jihye Park ₂ , Soo Jung Park ₂ , Jae Jun Park ₂ , Tae Il Kim _{2,

3} , Jae Seung Lee _{2,

4} , Hye Won Lee _{2,

4} , Beom Kyung Kim _{2,

4} , Jun Yong Park _{2,

4} , Do Young Kim _{2,

4} , Sang Hoon Ahn _{2,

4} , Seung Up Kim _{2,

4} , Jae Hee Cheon _{2,

3}

Affiliation

Behçet's disease (BD) and nonalcoholic fatty liver disease (NAFLD) are chronic inflammatory diseases that share pathogenetic mechanisms. In this study, we investigated whether NAFLD influences the clinical outcomes in patients with intestinal BD.

中文翻译：